Karriereverlauf von Masaharu Osato
Ehemalige bekannte Positionen von Masaharu Osato
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EMMAUS LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 17.07.2019 | 28.09.2022 |
Independent Dir/Board Member | 17.07.2019 | 28.09.2022 | |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Direktor/Vorstandsmitglied | 16.12.2015 | 22.07.2019 |
Tokyo Adventist Hospital | Corporate Officer/Principal | 01.01.1993 | 01.01.1997 |
Kobe Adventist Hospital | Corporate Officer/Principal | 01.01.1988 | 01.01.1993 |
Statistik
International
Vereinigte Staaten | 3 |
Japan | 3 |
Operativ
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EMMAUS LIFE SCIENCES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
Tokyo Adventist Hospital | |
Kobe Adventist Hospital |
- Börse
- Insiders
- Masaharu Osato
- Erfahrung